Reuters logo
BRIEF-Almirall gets positive CHMP opinion for drug to treat psoriasis
April 21, 2017 / 10:59 AM / 5 months ago

BRIEF-Almirall gets positive CHMP opinion for drug to treat psoriasis

April 21 (Reuters) - Almirall SA:

* Receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for dimethyl fumarate for the treatment of patients with moderate-to-severe chronic plaque psoriasis Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below